Sagimet Biosciences Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sagimet Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q2 2025.
  • Sagimet Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $152K, a 0.66% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $152K +$1K +0.66% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $38K +$1K +2.7% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $77K +$4K +5.48% Dec 31, 2024 10-Q 2025-08-13
Q3 2024 $114K +$5K +4.59% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $151K +$7K +4.86% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $37K Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $73K -$139K -65.6% Dec 31, 2023 10-K 2025-03-12
Q3 2023 $109K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $144K Jun 30, 2023 10-Q 2023-08-21
Q4 2022 $212K Dec 31, 2022 10-K 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.